278 related articles for article (PubMed ID: 25952786)
1. Molecular targets in glioblastoma.
Zorzan M; Giordan E; Redaelli M; Caretta A; Mucignat-Caretta C
Future Oncol; 2015; 11(9):1407-20. PubMed ID: 25952786
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathways and potential therapeutic targets in glioblastoma multiforme.
Wardak Z; Choe KS
Expert Rev Anticancer Ther; 2013 Nov; 13(11):1307-18. PubMed ID: 24168050
[TBL] [Abstract][Full Text] [Related]
3. SnapShot: glioblastoma multiforme.
Kotliarova S; Fine HA
Cancer Cell; 2012 May; 21(5):710-710.e1. PubMed ID: 22624719
[No Abstract] [Full Text] [Related]
4. Molecular characterizations of glioblastoma, targeted therapy, and clinical results to date.
Bastien JI; McNeill KA; Fine HA
Cancer; 2015 Feb; 121(4):502-16. PubMed ID: 25250735
[TBL] [Abstract][Full Text] [Related]
5. Cellular signaling molecules as therapeutic targets in glioblastoma multiforme.
Jagannathan J; Prevedello DM; Dumont AS; Laws ER
Neurosurg Focus; 2006 Apr; 20(4):E8. PubMed ID: 16709039
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic strategies targeting glioblastoma stem cells.
Carrasco-Garcia E; Sampron N; Aldaz P; Arrizabalaga O; Villanua J; Barrena C; Ruiz I; Arrazola M; Lawrie C; Matheu A
Recent Pat Anticancer Drug Discov; 2013 Sep; 8(3):216-27. PubMed ID: 23607282
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents.
Reardon DA; Wen PY
Oncologist; 2006 Feb; 11(2):152-64. PubMed ID: 16476836
[TBL] [Abstract][Full Text] [Related]
8. Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets.
Mao H; Lebrun DG; Yang J; Zhu VF; Li M
Cancer Invest; 2012 Jan; 30(1):48-56. PubMed ID: 22236189
[TBL] [Abstract][Full Text] [Related]
9. Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells.
Gan HK; van den Bent M; Lassman AB; Reardon DA; Scott AM
Nat Rev Clin Oncol; 2017 Nov; 14(11):695-707. PubMed ID: 28675164
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of EGFR-activated metabolic pathways in glioblastoma.
Gao Q; Lei T; Ye F
Expert Opin Investig Drugs; 2013 Aug; 22(8):1023-40. PubMed ID: 23731170
[TBL] [Abstract][Full Text] [Related]
11. Using the molecular classification of glioblastoma to inform personalized treatment.
Olar A; Aldape KD
J Pathol; 2014 Jan; 232(2):165-77. PubMed ID: 24114756
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents.
Minniti G; Muni R; Lanzetta G; Marchetti P; Enrici RM
Anticancer Res; 2009 Dec; 29(12):5171-84. PubMed ID: 20044633
[TBL] [Abstract][Full Text] [Related]
13. Molecular advances of brain tumors in radiation oncology.
Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
[TBL] [Abstract][Full Text] [Related]
14. DNA repair mechanisms and their clinical impact in glioblastoma.
Erasimus H; Gobin M; Niclou S; Van Dyck E
Mutat Res Rev Mutat Res; 2016; 769():19-35. PubMed ID: 27543314
[TBL] [Abstract][Full Text] [Related]
15. Molecular targeted therapy of glioblastoma.
Le Rhun E; Preusser M; Roth P; Reardon DA; van den Bent M; Wen P; Reifenberger G; Weller M
Cancer Treat Rev; 2019 Nov; 80():101896. PubMed ID: 31541850
[TBL] [Abstract][Full Text] [Related]
16. Toward precision medicine in glioblastoma: the promise and the challenges.
Prados MD; Byron SA; Tran NL; Phillips JJ; Molinaro AM; Ligon KL; Wen PY; Kuhn JG; Mellinghoff IK; de Groot JF; Colman H; Cloughesy TF; Chang SM; Ryken TC; Tembe WD; Kiefer JA; Berens ME; Craig DW; Carpten JD; Trent JM
Neuro Oncol; 2015 Aug; 17(8):1051-63. PubMed ID: 25934816
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma multiforme: Pathogenesis and treatment.
Alifieris C; Trafalis DT
Pharmacol Ther; 2015 Aug; 152():63-82. PubMed ID: 25944528
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma targeted therapy: updated approaches from recent biological insights.
Touat M; Idbaih A; Sanson M; Ligon KL
Ann Oncol; 2017 Jul; 28(7):1457-1472. PubMed ID: 28863449
[TBL] [Abstract][Full Text] [Related]
19. Extrachromosomal DNA: Redefining the pathogenesis of glioblastoma.
Shiras A; Mondal A
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188551. PubMed ID: 33892052
[TBL] [Abstract][Full Text] [Related]
20. Impact of molecular profiling on clinical trial design for glioblastoma.
Chakravarti A; Tyndall E; Palanichamy K; Mehta M; Aldape K; Loeffler J
Curr Oncol Rep; 2007 Jan; 9(1):71-9. PubMed ID: 17164051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]